Business Wire Feed
Hims & Hers Brings Comprehensive Weight Loss Programme to the UK
Expansion Debuts Hers, Unlocking Personalised Care for British Women LONDON--(BUSINESS WIRE)--Hims & Hers is deepening its commitment to the UK by bringing access to its comprehensive Weight Loss Programme to customers. This expansion includes the more...
Biocytogen Completes STAR Market IPO, Becoming the First “H+A” Global Drug Innovator
BEIJING & SHANGHAI & HONG KONG--(BUSINESS WIRE)--#AntibodyDiscovery--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen,” SSE: 688796; HKEX: 02315), a global biotechnology company advancing innovative drug discovery, today announced its successful listing on the Shanghai Stock Exchange STAR more...
Sainte Catherine, Institut du Cancer Avignon-Provence (ICAP), Becomes the First Center in Europe to Implement the Varian Latest Halcyon Advancements with Identify integration, PerfectKinetix Dynamic Couch and HyperSight for Personalized Radiotherapy
AVIGNON, France--(BUSINESS WIRE)--Institut du Cancer Avignon-Provence (ICAP), and Varian, a Siemens Healthineers company, announced today the first European installation of the Halcyon version 5.0 radiotherapy platform, combined with IDENTIFY real-time motion management, and the PerfectKinetix more...
Polpharma Biologics and Libbs Farmacêutica Sign Licensing Agreement for a Biosimilar for Autoimmune Diseases
ZUG, Switzerland--(BUSINESS WIRE)--Polpharma Biologics, a leading biopharmaceutical company specializing in the development and manufacturing of biosimilars, is thrilled to announce the signing of a landmark licensing agreement with the Brazilian company Libbs Farmacêutica! Through this more...
Rivalry Capital Launches as Next-Generation Private Equity Firm Focusing on Healthcare Transformation
DENVER--(BUSINESS WIRE)--Rivalry Capital today announced its official launch, introducing a next-generation private equity firm that combines applied mathematics and artificial intelligence with operational depth and clinical expertise. Founded by Jim Chandler CFA, Matt Young MBA, more...
HealthStream CEO Rewards Employees with Contribution of Personally Owned Shares of Company Stock
NASHVILLE, Tenn.--(BUSINESS WIRE)--HealthStream (Nasdaq: HSTM), a leading healthcare technology platform company for workforce solutions, today announced that its Chief Executive Officer, Robert A. Frist, Jr., has contributed approximately $3.5 million of his personally owned shares more...
Church & Dwight to Sell VitaFusion and L’il Critters Brands
EWING, N.J.--(BUSINESS WIRE)--Church & Dwight Co., Inc. (NYSE:CHD) has concluded its strategic review of its vitamin, minerals and supplement (VMS) business and is announcing today a definitive agreement to sell the VitaFusion® and L’il Critters® more...
Dentalcorp Obtains Final Court Approval for Acquisition by Investment Funds Affiliated With GTCR
TORONTO--(BUSINESS WIRE)--dentalcorp Holdings Ltd. (“Dentalcorp” or the “Company”) (TSX: DNTL) announced today that the Company has obtained a final order from the Supreme Court of British Columbia approving the previously-announced plan of arrangement whereby a more...
Nephrodite Announces Industry’s First Successful Multi-Day Large Animal Study for a Fully Implantable Renal Replacement Device
The Holly™ by Nephrodite device demonstrated continuous kidney function replacement in a large animal marking a critical milestone toward commercialization ATLANTA--(BUSINESS WIRE)--Nephrodite Inc., a medical device company developing an implantable, continuous dialysis system, today announced more...
SonicEdge and Earfab Partner to Shape the Future of Personalized Audio and Hearing Wellness
Partnership unites SonicEdge’s micro-speaker technology with Earfab’s custom-fit innovation to deliver unmatched comfort and fidelity BINYAMINA-GIV’AT ADA, Israel--(BUSINESS WIRE)--SonicEdge, a pioneer in micro-acoustic innovation, today announced a strategic partnership with Earfab, the innovator of custom-fit more...
The Mother Baby Center Locations at United and Mercy Hospitals Earn Top Rating from U.S. News and World Report
MINNEAPOLIS & ST. PAUL, Minn.--(BUSINESS WIRE)--#TheKidExperts--The Mother Baby Center, a partnership between Allina Health and Children’s Minnesota, is pleased to announce that its locations at United Hospital in St. Paul and Mercy Hospital in Coon more...
MedeAnalytics and Basys.ai Announce Strategic Partnership to Transform Healthcare Utilization Management, Improve MLR
RICHARDSON, Texas--(BUSINESS WIRE)--#agenticai--MedeAnalytics, an industry pioneer in AI-powered enterprise healthcare intelligence, analytics, and data management, and Basys.ai, an innovation leader in agentic AI for healthcare, today announced a strategic partnership designed to accelerate decision-making, reduce more...
LifeScan Successfully Emerges from Financial Restructuring Process, Enters Next Chapter with Renewed Strength
Eliminates More Than 75% of Prepetition Debt, Positioning Company to Improve Product Affordability and Availability in Key Markets New Ownership Group to Support LifeScan’s Commitment to Improving Life for People with Diabetes MALVERN, Pa.--(BUSINESS WIRE)--LifeScan more...
From Novel Therapies to First-in-Human Trials, City of Hope Advances Blood Cancer Care at the American Society of Hematology (ASH) Annual Conference
City of Hope presented research spanning novel therapies, innovative treatment combinations and new approaches to managing complications, underscoring its leadership in hard-to-treat and high-risk diseases. LOS ANGELES--(BUSINESS WIRE)--Researchers from City of Hope®, one of the more...
Swisslog Healthcare Unveils Allegro™ to Pharmacy Leaders at Largest US Industry Event
Advanced robotic technology will maximize workflow efficiency with unmatched scalability High-speed robotic technology accelerates pharmacy operations Modular design provides flexibility within existing infrastructure and evolving consolidated service models Web-based platform enables remote access and seamless more...
ChiroTouch Unveils Compliance Scan, Delivering AI-Powered Documentation Accuracy and Audit Protection to Chiropractors
SAN DIEGO--(BUSINESS WIRE)--#ChiroTouch--Claim denials and documentation errors can drain up to 30% of a chiropractic practice’s expected collections, creating significant financial and regulatory pressure for practices. In response, ChiroTouch today announced Compliance Scan: a new more...
Genentech Presents Lunsumio Data Showing Potential Across Earlier Treatment Lines in Indolent and Aggressive Lymphomas
– Lunsumio in combination with lenalidomide may offer an effective treatment in relapsed or refractory follicular lymphoma based on first data from single-arm cohort of Phase III CELESTIMO study – – Data from subcutaneous Lunsumio more...
Incyte Presents Updated Positive Data at ASH 2025 Reinforcing the Potential of INCA033989, its First-in-Class mutCALR-Targeted Monoclonal Antibody, in Patients with Essential Thrombocythemia
Nearly all (90%) of essential thrombocythemia (ET) patients treated with INCA033989 at the higher dose achieved a hematologic response (HR) with 83.3% achieving a complete HR Molecular responses were frequent, rapid, durable and correlated with more...
Genmab Announces New Data from Phase 1b/2 EPCORE® CLL-1 Highlighting Potential of Epcoritamab as Monotherapy and in Combination for Patients with Richter Transformation (RT)
Two-year epcoritamab monotherapy data demonstrate high complete response and encouraging survival rates in patients with Richter transformation (RT), highlighting its potential as a treatment option for those unsuitable for chemotherapy Additional early data show promising more...
PureTech Announces Successful End-of-Phase 2 Meeting with FDA for Deupirfenidone (LYT-100) in Idiopathic Pulmonary Fibrosis
Feedback from U.S. Food and Drug Administration (FDA) supports advancement into a pivotal Phase 3 trial and a 505(b)(2) regulatory pathway Phase 3 SURPASS-IPF trial remains on track to be initiated by PureTech’s Founded Entity, more...
Merz Therapeutics to Present Broad Range of Clinical, Real-World and Mechanistic Data at TOXINS 2026
Merz Therapeutics to present more than 20 abstracts and posters at the TOXINS 2026 8th International Conference, taking place January 14-17 2026 in Madrid, Spain. FRANKFURT, Germany--(BUSINESS WIRE)--Merz Therapeutics, a leading player in neurology-focused specialty more...
Galderma Welcomes Increased Equity Investment From L’Oréal
L’Oréal to acquire an additional 10% stake in Galderma recognizing its scientific leadership in dermatology and long-term growth potential Ad hoc announcement pursuant to Art. 53 LR ZUG, Switzerland--(BUSINESS WIRE)--Galderma Group AG (SIX:GALD), the pure-play more...
Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies
Novel BCL2 inhibitor sonrotoclax monotherapy demonstrates deep and durable clinical responses in R/R MCL and R/R CLL Sonrotoclax in combination with BRUKINSA demonstrated rapid MRD negativity in treatment-naive CLL, regardless of high-risk features SAN CARLOS, more...
Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH
VIENNA--(BUSINESS WIRE)--#AOPHealth--AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the more...
Incyte Announces New Positive Data for INCA033989, its First-In-Class mutCALR-Targeted Monoclonal Antibody, in Patients with Myelofibrosis Presented at ASH 2025
Rapid and robust reductions in spleen volume and symptoms, and improvements in anemia were observed with INCA033989 as monotherapy and in combination with ruxolitinib (Jakafi®) in patients with myelofibrosis (MF) harboring a CALR mutation (mutCALR) more...